These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

301 related items for PubMed ID: 20544054

  • 1. The role of statins in managing diabetic dyslipidemia.
    Toth PP.
    J Fam Pract; 2010 May; 59(5 Suppl):S23-9. PubMed ID: 20544054
    [Abstract] [Full Text] [Related]

  • 2. Benefits of lipid-lowering therapy in patients with type 2 diabetes mellitus.
    Betteridge J.
    Am J Med; 2005 Dec; 118 Suppl 12A():10-5. PubMed ID: 16356802
    [Abstract] [Full Text] [Related]

  • 3. Management of dyslipidemia in diabetes.
    Solano MP, Goldberg RB.
    Cardiol Rev; 2006 Dec; 14(3):125-35. PubMed ID: 16628021
    [Abstract] [Full Text] [Related]

  • 4. [Lipid-lowering cardiovascular prevention in type 2-diabetes. Statins are effective according to the FIELD study].
    Båvenholm P, Attvall S, Nilsson PM.
    Lakartidningen; 2006 Dec; 103(35):2462-6. PubMed ID: 17002161
    [No Abstract] [Full Text] [Related]

  • 5. Impact of managing atherogenic dyslipidemia on cardiovascular outcome across different stages of diabetic nephropathy.
    Athyros VG, Mitsiou EK, Tziomalos K, Karagiannis A, Mikhailidis DP.
    Expert Opin Pharmacother; 2010 Apr; 11(5):723-30. PubMed ID: 20210681
    [Abstract] [Full Text] [Related]

  • 6. Clinical significance of recent lipid trials on reducing risk in patients with type 2 diabetes mellitus.
    Jones PH.
    Am J Cardiol; 2007 Feb 19; 99(4A):133B-140B. PubMed ID: 17307065
    [Abstract] [Full Text] [Related]

  • 7. Drug insight: the role of statins in combination with ezetimibe to lower LDL cholesterol.
    Gotto AM, Farmer JA.
    Nat Clin Pract Cardiovasc Med; 2006 Dec 19; 3(12):664-72. PubMed ID: 17122799
    [Abstract] [Full Text] [Related]

  • 8. Statins and diabetes.
    Carmena R, Betteridge DJ.
    Semin Vasc Med; 2004 Nov 19; 4(4):321-32. PubMed ID: 15861314
    [Abstract] [Full Text] [Related]

  • 9. A review of the current status of the management of mixed dyslipidemia associated with diabetes mellitus and metabolic syndrome.
    Davidson M.
    Am J Cardiol; 2008 Dec 22; 102(12A):19L-27L. PubMed ID: 19084086
    [Abstract] [Full Text] [Related]

  • 10. Interpreting clinical trials of diabetic dyslipidaemia: new insights.
    Wierzbicki AS.
    Diabetes Obes Metab; 2009 Mar 22; 11(3):261-70. PubMed ID: 17645560
    [Abstract] [Full Text] [Related]

  • 11. Lipid-lowering therapy in patients with type 2 diabetes: the case for early intervention.
    Steinmetz A.
    Diabetes Metab Res Rev; 2008 Mar 22; 24(4):286-93. PubMed ID: 18273835
    [Abstract] [Full Text] [Related]

  • 12. Management of mixed dyslipidemia in patients with or at risk for cardiovascular disease: a role for combination fibrate therapy.
    Fazio S.
    Clin Ther; 2008 Feb 22; 30(2):294-306. PubMed ID: 18343268
    [Abstract] [Full Text] [Related]

  • 13. Type 2 diabetes, dyslipidemia, and vascular risk: rationale and evidence for correcting the lipid imbalance.
    Carmena R.
    Am Heart J; 2005 Nov 22; 150(5):859-70. PubMed ID: 16290951
    [Abstract] [Full Text] [Related]

  • 14. Fibrates and future PPARalpha agonists in the treatment of cardiovascular disease.
    Staels B, Maes M, Zambon A.
    Nat Clin Pract Cardiovasc Med; 2008 Sep 22; 5(9):542-53. PubMed ID: 18628776
    [Abstract] [Full Text] [Related]

  • 15. Recent advances in the treatment of atherogenic dyslipidemia in type 2 diabetes mellitus.
    Wanner C, Krane V.
    Kidney Blood Press Res; 2011 Sep 22; 34(4):209-17. PubMed ID: 21691123
    [Abstract] [Full Text] [Related]

  • 16. Statin therapy in the primary and secondary prevention of coronary artery disease in patients with type 2 diabetes. A scientific review.
    Paulo S, Fernandes S, Vizinho R, Carneiro AV.
    Rev Port Cardiol; 2004 Nov 22; 23(11):1461-82. PubMed ID: 15693698
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of statins in the treatment of diabetic dyslipidemia.
    Berriche O, Amrouche C, Jamoussi H, Blouza S.
    Tunis Med; 2010 Feb 22; 88(2):80-4. PubMed ID: 20415163
    [Abstract] [Full Text] [Related]

  • 18. The effects of lipid-lowering drug therapy on cardiovascular responsiveness in type 2 diabetic patients.
    Howes LG.
    Diabetes Obes Metab; 2006 Jan 22; 8(1):8-14. PubMed ID: 16367877
    [Abstract] [Full Text] [Related]

  • 19. [Diabetic dyslipoproteinemia: beyond LDL].
    Merkel M.
    Dtsch Med Wochenschr; 2009 May 22; 134(20):1067-73. PubMed ID: 19421932
    [Abstract] [Full Text] [Related]

  • 20. Management of dyslipidemias in patients with diabetes and chronic kidney disease.
    Molitch ME.
    Clin J Am Soc Nephrol; 2006 Sep 22; 1(5):1090-9. PubMed ID: 17699330
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.